Key result
A Korean-specific anticholinergic burden scale was developed, categorizing 494 medications (56 strong, 23 moderate, 59 weak, and 356 with no anticholinergic activity).
Why the study?
The study was conducted to develop the Korean Anticholinergic Burden Scale specific for Korean older adults.
Systematic Review
The development of the Korean Anticholinergic Burden Scale provides a consensus-driven tool to assess anticholinergic burden in older adults with polypharmacy in Korea.
No takes yet. Share an insight, caveat, or question.
Offers a consensus-driven scale for Korean clinicians assessing anticholinergic burden in polypharmacy; extends prior tools to an East Asian context.
Jun et al. (2019) conducted a systematic review in Anticholinergic burden in older adults. Korean Anticholinergic Burden Scale was evaluated on Anticholinergic scores of medications. A Korean-specific anticholinergic burden scale was developed, categorizing 494 medications (56 strong, 23 moderate, 59 weak, and 356 with no anticholinergic activity).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: